Xavier Cos

Xavier Cos

Auto-generated profile, based on publicly available information

Xavier Cos

Sant Marti de Provençals Primary Care Centres, Institut Català de la Salut, Barcelona, Spain; University Research Institute in Primary Care (IDIAP Jordi Gol), Barcelona, Spain

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 April 2010 in Hormone and Metabolic Research
Verified
Journal Article
Closed access
PDF file
BPB. Paulweber
B. Paulweber
PVP. Valensi
P. Valensi
JLJaana Lindström
Jaana Lindström
NLN. Lalic
N. Lalic
CGC. Greaves
C. Greaves
TYT. Yilmaz
T. Yilmaz
Background: The prevalence and socioeconomic burden of type 2 diabetes (T2DM) and associated co-morbidities are rising worldwide. Aims: This guideline provides evidence-based recommendations for preventing T2DM. Methods: A European multidisciplinary consortium systematically reviewed the evidence on the effectiveness of screening and interventions for T2DM prevention using SIGN criteria. Results: Obesity and sedentary lifestyle are the main modifiable risk factors. Age and ethnicity are non-modifiable risk factors. Case-finding should follow a step-wise procedure using risk questionnaires and oral glucose tolerance testing. Persons with impaired glucose tolerance and/or fasting glucose are at high-risk and should be prioritized for intensive intervention. Interventions supporting lifestyle changes delay the onset of T2DM in high-risk adults (number-needed-to-treat: 6.4 over 1.8–4.6 years). These should be supported by inter-sectoral strategies that create health promoting environments. Sustained body weight reduction by ≥ 5 % lowers risk. Currently metformin, acarbose and orlistat can be considered as second-line prevention options. The population approach should use organized measures to raise awareness and change lifestyle with specific approaches for adolescents, minorities and disadvantaged people. Interventions promoting lifestyle changes are more effective if they target both diet and physical activity, mobilize social support, involve the planned use of established behaviour change techniques, and provide frequent contacts. Cost-effectiveness analysis should take a societal perspective. Conclusions: Prevention using lifestyle modifications in high-risk individuals is cost-effective and should be embedded in evaluated models of care. Effective prevention plans are predicated upon sustained government initiatives comprising advocacy, community support, fiscal and legislative changes, private sector engagement and continuous media communication.

13 April 2010 in Hormone and Metabolic Research
Verified
Journal Article
Closed access
PDF file
JLJaana Lindström
Jaana Lindström
ANA. Neumann
A. Neumann
KSK. Sheppard
K. Sheppard
AGA. Gilis-Januszewska
A. Gilis-Januszewska
CGC. Greaves
C. Greaves
TYT. Yilmaz
T. Yilmaz
When we ask people what they value most, health is usually top of the list. While effective care is available for many chronic diseases, the fact remains that for the patient, the tax payer and the whole of society: Prevention is Better Than Cure. Diabetes and its complications are a serious threat to the survival and well-being of an increasing number of people. It is predicted that one in ten Europeans aged 20–79 will have developed diabetes by 2030. Once a disease of old age, diabetes is now common among adults of all ages and is beginning to affect adolescents and even children. Diabetes accounts for up to 18 % of total healthcare expenditure in Europe. The Good News is That Diabetes is Preventable. Compelling evidence shows that the onset of diabetes can be prevented or delayed greatly in individuals at high risk (people with impaired glucose regulation). Clinical research has shown a reduction in risk of developing diabetes of over 50 % following relatively modest changes in lifestyle that include adopting a healthy diet, increasing physical activity, and maintaining a healthy body weight. These results have since been reproduced in real-world prevention programmes. Even a delay of a few years in the progression to diabetes is expected to reduce diabetes-related complications, such as heart, kidney and eye disease and, consequently, to reduce the cost to society. A comprehensive approach to diabetes prevention should combine population based primary prevention with programmes targeted at those who are at high risk. This approach should take account of the local circumstances and diversity within modern society (e.g. social inequalities). The challenge goes beyond the healthcare system. We need to encourage collaboration across many different sectors: education providers, non-governmental organisations, the food industry, the media, urban planners and politicians all have a very important role to play. Small Changes in Lifestyle Will Bring Big Changes in Health.
Through Joint Efforts, More People Will be Reached.
The Time to Act is Now.

1 March 2018 in Diabetes Research and Clinical Practice
Verified
Journal Article
Closed access
KKKamlesh Khunti
Kamlesh Khunti
ACAntonio Ceriello
Antonio Ceriello
XCXavier Cos
Xavier Cos
CBChristophe De Block
Christophe De Block

10 February 2012 in Diabetologia
Verified
Journal Article
Closed access
PDF file
TGThe DE-PLAN-CAT Research Group
The DE-PLAN-CAT Research Group
BCB. Costa
B. Costa
FBF. Barrio
F. Barrio
JCJuan Cabre
Juan Cabre
JPJ.-L. Piñol
J.-L. Piñol
JTJ. Tuomilehto
J. Tuomilehto

1 April 2019 in Diabetes, Obesity and Metabolism
Verified
Journal Article
Closed access
PDF file
SSSamuel Seidu
Samuel Seidu
Setor K KunutsorSetor K Kunutsor
Setor K Kunutsor
PTPinar Topsever
Pinar Topsever
CHClare Elizabeth Hambling
Clare Elizabeth Hambling
FCFrancesc Xavier Cos
Francesc Xavier Cos
KKKamlesh Khunti
Kamlesh Khunti

1 September 2014 in Diabetes Research and Clinical Practice
Verified
Journal Article
Open access
WSWilliam David Strain
William David Strain
XCX. Cos
X. Cos
MHM. Hirst
M. Hirst
SVS. Vencio
S. Vencio
VMV. Mohan
V. Mohan
PPP.M. Paldánius
P.M. Paldánius
Clinical inertia, the tendency to maintain current treatment strategies despite results demanding escalation, is thought to substantially contribute to the disconnect between clinical aspirations for patients with diabetes and targets achieved. We wished to explore potential causes of clinical inertia among physicians and people with diabetes. A 20-min online survey of 652 adults with diabetes and 337 treating physicians in six countries explored opinions relating to clinical inertia from both perspectives, in order to correlate perceptions and expectations relating to diagnosis, treatment, diabetes complications and therapeutic escalation. Physicians had low expectations for their patients, despite the belief that the importance of good glycaemic control through lifestyle and pharmacological interventions had been adequately conveyed. Conversely, people with diabetes had, at best, a rudimentary understanding of the risks of complications and the importance of good control; indeed, only a small proportion believed lifestyle changes were important and the majority did not intend to comply. The principal findings of this survey suggest that impairments in communication are at the heart of clinical inertia. This manuscript lays out four key principles that we believe are achievable in all environments and can improve the lives of people with diabetes.